References
Identifying CD82 (KAI1) as a marker for human chromophobe renal cell carcinoma. Yusenko MV, Kovacs G. Histopathology. 2009 Dec;55(6):687-95. PMID: 20002769
KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis. Malik FA, Sanders AJ, Jiang WG. Histol Histopathol. 2009 Apr;24(4):519-30. PMID: 19224455
Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis. Bari R, Zhang YH, Zhang F, Wang NX, Stipp CS, Zheng JJ, Zhang XA. Am J Pathol. 2009 Feb;174(2):647-60. PMID: 19116362
KAI1/CD82, a tumor metastasis suppressor. Liu WM, Zhang XA. Cancer Lett. 2006 Aug 28;240(2):183-94. PMID: 16260083
Tonoli H, Barrett JC. CD82 metastasis suppressor gene: a potential target for new therapeutics? Trends Mol Med. 2005 Nov 2; PMID: 16271511